MYELOPROLIPHERATIVE NEOPLSM

Clinical trials for MYELOPROLIPHERATIVE NEOPLSM explained in plain language.

Never miss a new study

Get alerted when new MYELOPROLIPHERATIVE NEOPLSM trials appear

Sign up with your email to follow new studies for MYELOPROLIPHERATIVE NEOPLSM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for toughest blood cancers: scientists tweak transplant drugs to fight disease and spare patients

Disease control Recruiting now

This study aims to improve outcomes for patients with high-risk blood cancers who receive a stem cell transplant from a partially matched donor. Researchers are testing a modified combination of two drugs (bendamustine and cyclophosphamide) given after the transplant. The goal is…

Matched conditions: MYELOPROLIPHERATIVE NEOPLSM

Phase: PHASE2 • Sponsor: St. Petersburg State Pavlov Medical University • Aim: Disease control

Last updated Mar 31, 2026 12:10 UTC

MYELOPROLIPHERATIVE NEOPLSM

Get alerted when new MYELOPROLIPHERATIVE NEOPLSM trials appear

New hope for toughest blood cancers: scientists tweak transplant drugs to fight disease and spare patients